1. Home
  2. ABOS vs SRFM Comparison

ABOS vs SRFM Comparison

Compare ABOS & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • SRFM
  • Stock Information
  • Founded
  • ABOS 1996
  • SRFM 2011
  • Country
  • ABOS United States
  • SRFM United States
  • Employees
  • ABOS N/A
  • SRFM N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • SRFM Transportation Services
  • Sector
  • ABOS Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • ABOS 72.7M
  • SRFM 58.2M
  • IPO Year
  • ABOS 2021
  • SRFM 2023
  • Fundamental
  • Price
  • ABOS $1.18
  • SRFM $3.71
  • Analyst Decision
  • ABOS Strong Buy
  • SRFM Buy
  • Analyst Count
  • ABOS 4
  • SRFM 4
  • Target Price
  • ABOS $6.50
  • SRFM $5.56
  • AVG Volume (30 Days)
  • ABOS 571.8K
  • SRFM 12.9M
  • Earning Date
  • ABOS 08-12-2025
  • SRFM 08-13-2025
  • Dividend Yield
  • ABOS N/A
  • SRFM N/A
  • EPS Growth
  • ABOS N/A
  • SRFM N/A
  • EPS
  • ABOS N/A
  • SRFM N/A
  • Revenue
  • ABOS N/A
  • SRFM $112,307,000.00
  • Revenue This Year
  • ABOS N/A
  • SRFM N/A
  • Revenue Next Year
  • ABOS N/A
  • SRFM $54.32
  • P/E Ratio
  • ABOS N/A
  • SRFM N/A
  • Revenue Growth
  • ABOS N/A
  • SRFM 31.17
  • 52 Week Low
  • ABOS $0.86
  • SRFM $0.90
  • 52 Week High
  • ABOS $3.60
  • SRFM $6.72
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 56.83
  • SRFM 59.72
  • Support Level
  • ABOS $1.05
  • SRFM $1.77
  • Resistance Level
  • ABOS $1.28
  • SRFM $4.16
  • Average True Range (ATR)
  • ABOS 0.09
  • SRFM 0.71
  • MACD
  • ABOS 0.01
  • SRFM 0.15
  • Stochastic Oscillator
  • ABOS 61.54
  • SRFM 41.58

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: